scholarly article | Q13442814 |
P50 | author | Annabella Di Giorgio | Q46431616 |
Paolo Taurisano | Q46431634 | ||
Giuseppe Blasi | Q55999215 | ||
P2093 | author name string | Wolfgang Sadee | |
Alessandro Bertolino | |||
Danxin Wang | |||
Antonio Rampino | |||
Audrey Papp | |||
Grazia Caforio | |||
Leonardo Fazio | |||
Raffaella Romano | |||
Teresa Popolizio | |||
Marcello Nardini | |||
Julia Pinsonneault | |||
P2860 | cites work | Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects | Q22248075 |
Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia | Q24532517 | ||
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia | Q24676113 | ||
Distinct functions of the two isoforms of dopamine D2 receptors | Q28138415 | ||
Intermediate phenotypes and genetic mechanisms of psychiatric disorders | Q28264588 | ||
A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms | Q28270982 | ||
Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database | Q28285397 | ||
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons | Q28589923 | ||
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum | Q28592815 | ||
Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors | Q28594153 | ||
Implications of normal brain development for the pathogenesis of schizophrenia | Q29618740 | ||
Cortical effects of bromocriptine, a D-2 dopamine receptor agonist, in human subjects, revealed by fMRI. | Q32164608 | ||
Neurotransmitter interactions in schizophrenia--therapeutic implications | Q33782626 | ||
Imaging dopamine transmission in schizophrenia. A review and meta-analysis. | Q34477992 | ||
Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine | Q35023131 | ||
The principal features and mechanisms of dopamine modulation in the prefrontal cortex | Q35894171 | ||
Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. | Q36300098 | ||
Post-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophrenia. | Q36389548 | ||
Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia | Q36500321 | ||
Prominence of the dopamine D2 short isoform in dopaminergic pathways | Q36507451 | ||
Dopaminergic enhancement of cognitive function | Q36536386 | ||
Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human heart tissues | Q37208437 | ||
Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan. | Q37371260 | ||
False positives in imaging genetics | Q38428130 | ||
Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. | Q40392922 | ||
D2 dopamine receptors recruit a GABA component for their attenuation of excitatory synaptic transmission in the adult rat prefrontal cortex | Q41818907 | ||
Effects of dopaminergic transmission interruption on the D2 receptor isoforms in various cerebral tissues | Q43514176 | ||
The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms | Q43944971 | ||
Prefrontal dopamine D1 receptors and working memory in schizophrenia. | Q43972774 | ||
Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia | Q44639449 | ||
Systemic sulpiride modulates striatal blood flow: relationships to spatial working memory and planning | Q44698425 | ||
Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study | Q44752395 | ||
Selective D2 receptor actions on the functional circuitry of working memory | Q44757222 | ||
Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function | Q44893993 | ||
Functional lateralization of the sensorimotor cortex in patients with schizophrenia: effects of treatment with olanzapine | Q44991309 | ||
Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. | Q45091251 | ||
Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457. | Q46367916 | ||
Catechol-O-methyltransferase Val158Met modulation of prefrontal-parietal-striatal brain systems during arithmetic and temporal transformations in working memory | Q46868066 | ||
Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. | Q46942995 | ||
Dopamine D2 receptor occupancy levels of acute sulpiride challenges that produce working memory and learning impairments in healthy volunteers | Q46969767 | ||
Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing. | Q48103142 | ||
Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down | Q48135229 | ||
Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. | Q48282054 | ||
Prefrontal dysfunction in schizophrenia controlling for COMT Val158Met genotype and working memory performance | Q48429196 | ||
Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) in human brain: dissection of epigenetic and genetic factors | Q48452772 | ||
Spatial attention and memory versus motor preparation: premotor cortex involvement as revealed by fMRI. | Q48475245 | ||
Impact of complex genetic variation in COMT on human brain function | Q48492697 | ||
Antipsychotic regulation of dopamine D1, D2 and D3 receptor mRNA. | Q48502124 | ||
Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. | Q48586204 | ||
Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs. | Q48748788 | ||
Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. | Q48800661 | ||
Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. | Q52023542 | ||
Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. | Q52051956 | ||
Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys. | Q52053207 | ||
Single nucleotide polymorphism genotyping using allele-specific PCR and fluorescence melting curves | Q73433725 | ||
Altered dopaminergic function and negative symptoms in drug-free patients with schizophrenia. [123I]-iodobenzamide SPECT study | Q74369401 | ||
P433 | issue | Pt 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dopamine | Q170304 |
striatum | Q1319792 | ||
schizophrenia | Q41112 | ||
P304 | page(s) | 417-425 | |
P577 | publication date | 2008-10-01 | |
P1433 | published in | Brain | Q897386 |
P1476 | title | Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia | |
P478 | volume | 132 |